Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Tricida Inc
(NQ:
TCDA
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Jan 23, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tricida Inc
< Previous
1
2
3
4
Next >
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Tricida, Inc. (TCDA) and Encourages Long-Term TCDA Stockholders to Contact the Firm
October 13, 2022
From
Kaskela Law LLC
Via
Business Wire
Coinbase Global And 3 Other Stocks Insiders Are Buying
October 07, 2022
Although US stocks closed lower on Thursday, there were a few notable insider trades.
Via
Benzinga
$17 Million Bet On This Technology Stock? 3 Stocks Insiders Are Buying
October 04, 2022
Although US stocks closed higher on Monday, there were a few notable insider trades.
Via
Benzinga
Tricida Announces the Selection of the VALOR-CKD Trial for an Oral Presentation in the High-Impact Clinical Trials Session at ASN Kidney Week 2022
October 03, 2022
From
Tricida, Inc.
Via
Business Wire
Analyst Ratings for Tricida
May 24, 2022
Within the last quarter, Tricida (NASDAQ:TCDA) has observed the following analyst ratings:
Via
Benzinga
Read Why Did Tricida Stop VALOR-CKD Renal Outcomes Trial Early
May 19, 2022
Via
Benzinga
Micron, Charles River Laboratories And Some Other Big Stocks Moving Higher On Friday
September 30, 2022
U.S. stocks traded slightly higher, with the Nasdaq Composite gaining more than 80 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Over $352 Million Bet On Occidental Petroleum? 3 Stocks Insiders Are Buying
September 29, 2022
Although US stocks closed higher on Wednesday, there were a few notable insider trades.
Via
Benzinga
TRICIDA INVESTIGATION CONTINUED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Tricida, Inc. - TCDA
September 23, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
September 20, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Around $8 Million Bet On This Biotechnology Stock? 3 Stocks Insiders Are Buying
September 08, 2022
Although US stocks closed higher on Wednesday, there were a few notable insider trades.
Via
Benzinga
Tricida to Present at the H.C. Wainwright 24th Annual Global Investment Conference
September 06, 2022
From
Tricida, Inc.
Via
Business Wire
15 Biotech Stocks That Hit Year Highs Over The Last Week, Including Sarepta, Axsome
August 30, 2022
Not all shares are slowing down alongside the industry group.
Via
Investor's Business Daily
TRICIDA INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Tricida, Inc. - TCDA
August 26, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
August 10, 2022
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.
Via
Benzinga
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
August 09, 2022
Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD....
Via
Benzinga
Tricida Announces Second Quarter 2022 Financial Results
August 08, 2022
From
Tricida, Inc.
Via
Business Wire
Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners
July 21, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
$1.4 Million Bet On This Biotechnology Stock? 3 Stocks Insiders Are Buying
July 21, 2022
Although US stocks closed higher on Wednesday, there were a few notable insider trades.
Via
Benzinga
$7.6 Million Bet On GMS? 3 Stocks Insiders are Buying
June 27, 2022
Although the US stocks closed sharply higher on Friday, there were a few notable insider trades.
Via
Benzinga
Insiders Buy More Than $15M Of 3 Stocks
June 10, 2022
Although the Dow Jones dropped by more than 600 points on Thursday, there were a few notable insider trades.
Via
Benzinga
Earnings Scheduled For August 8, 2022
August 08, 2022
Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings for its second quarter.
Via
Benzinga
Tricida: Q1 Earnings Insights
May 10, 2022
Tricida (NASDAQ:TCDA) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Tricida beat estimated earnings by...
Via
Benzinga
Tricida's Earnings: A Preview
May 09, 2022
Tricida (NASDAQ:TCDA) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Tricida will report...
Via
Benzinga
54 Biggest Movers From Yesterday
April 20, 2022
Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) shares jumped 325.9% to close at $10.35 on Tuesday after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to...
Via
Benzinga
Earnings Scheduled For May 10, 2022
May 10, 2022
Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022
April 13, 2022
Upgrades
Via
Benzinga
The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia
March 29, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Earnings Scheduled For March 29, 2022
March 29, 2022
Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is projected to report quarterly loss at $0.02 per share on revenue of $15.62 million.
Via
Benzinga
Earnings Preview: Tricida
March 28, 2022
Tricida (NASDAQ:TCDA) is set to give its latest quarterly earnings report on Tuesday, 2022-03-29. Here's what investors need to know before the announcement. Analysts estimate that Tricida will report...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.